Expert Consensus Panel Recommendation for Incorporating Lp-PLA2 Testing into Cardiovascular Disease Risk Assessment ... (ttacks and strokes. The consensus panel...)

HOME >> BIOLOGY >> TECHNOLOGY

Expert Consensus Panel Recommendation for Incorporating Lp-PLA2 Testing into Cardiovascular Disease Risk Assessment Guidelines

Date:6/23/2008

ttacks and strokes." The consensus panel also endorsed a simplified framework for traditional Framingham risk factor assessment in which any patient with two risk factors is recommended for Lp-PLA2 testing, given that most individuals with two risk factors are at moderate CV risk. In addition, a clinical cutpoint for Lp-PLA2 of >200 ng/mL was recommended for considering a patient at higher risk.

In the paper entitled "Lp-PLA2 and Risk of Stroke", Philip Gorelick, MD, MPH, Professor and Head of Neurology, University of Illinois College of Medicine, provides a review of several prospective epidemiological studies of Lp-PLA2 and stroke risk, and states that "determining patients at high risk for stroke may be challenging because total and LDL cholesterol may not predict stroke risk very well." The panel recommends testing Lp-PLA2 to help identify moderate-risk individuals who may be at high risk of stroke for whom more intensive lifestyle and pharmacotherapies may be indicated to reduce stroke and other major vascular events.

In his paper entitled "Lp-PLA2: An Independent Predictor of Coronary Events in Primary and Secondary Prevention," Jeffrey Anderson, MD, Professor of Medicine (Cardiology), University of Utah School of Medicine reported: "Lp- PLA2 appears to be highly specific for high atherosclerotic disease activity, independent and additive to traditional risk factors and metabolic syndrome. As such, Lp-PLA2 could alert the clinician to initiate proven strategies for coronary event and stroke reduction."

Both a PDF of the supplement and a searchable text version can be found on The American Journal of Cardiology website at: http://www.ajconline.org/issues/contents?issue_key=S0002-9149(08)X0017-7

ABOUT DIADEXUS

diaDexus, Inc., the educational sponsor of this supplement, is a privately held diagnostics company based in South San Francisco, C
'/>"/>

SOURCE diaDexus, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related biology technology :

1. PAREXEL Experts to Address Key Industry Topics at the Drug Information Association 44th Annual Meeting
2. Experts From The Peer Group Provide Training on Dialogue-Based Influence at the SPBT Annual Conference
3. PAREXEL Product Development and Regulatory Experts to Attend the 2008 BIO International Convention
4. BioStorage Technologies Forms Scientific Advisory Board with Leading Life Science Experts
5. Bio-Pharma Industry Experts Deliver M&A Value Through Integration Excellence
6. Regenesis Biomedical Appoints Scientific Advisory Board Composed of Life Science and Electronics Experts
7. International Wound Care Experts, Medline Announce Pressure Ulcer Prevention Consensus Paper
8. Federal government taps NC State experts to explain nanotech risks
9. Innovative and Forward-Thinking Experts to Deliver Keynote Presentations at IBCs 13th Annual Drug Discovery & Development of Innovative Therapeutics World Congress
10. Vermillions Roundtable Teleconference Highlights Peripheral Artery Disease Diagnostic Program; Features Commentary from Vascular Medicine Expert
11. Experts prove the geochemical origin of part of the CO2 emissions in semiarid climates

Post Your Comments:

(Date:5/21/2013)... (PRWEB) May 21, 2013 Many have ... as contributor to acne. Recently physicians from Clinical ... mental stress on the skin, and suggested using ... reduce the chemicals produced from stress that cause acne. ... the negative feelings acne brings about, stress causes changes ...

(Date:5/21/2013)... , May 21, 2013 Personal Genome Diagnostics ... its proprietary methodologies and expertise in genomic analysis ... targets in collaboration with Blueprint Medicines. PGDx is ... identifying genomic alterations in tumors, and Blueprint Medicines ... inhibitors for a genetically defined patient population. ...

(Date:5/21/2013)... (PRWEB) May 21, 2013 Inflamax ... of the ITN to design the study, which ... two key clinical models used in the study ... and Nasal Allergen Challenge (NAC) models. Although both ... numerous publications, to date no direct comparison between ...

(Date:5/21/2013)... (PRWEB) May 21, 2013 PathoGenetix, Inc., ... bacterial strain typing, announced today that it has successfully ... E. coli strains obtained from the Centers for Disease ... Scanning™ (GSS™) technology. The findings are detailed in a ... the American Society for Microbiology in Denver on Monday. ...

Breaking Biology Technology:Adult Acne Treatment, Probiotic Action Explains How Hypnotherapy and Probiotics May Cure Various Skin Conditions 2 Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets 2 Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets 3 Inflamax Research selected by the Immune Tolerance Network and the National Institutes of Health to conduct a landmark clinical study on the underlying mechanisms of allergic inflammation. 2 New Genotyping System Identifies Pathogenic E. coli Outbreak Strains 2 New Genotyping System Identifies Pathogenic E. coli Outbreak Strains 3

[0] Adult Acne Treatment, Probiotic Action Explains How Hypnotherapy and Probiotics May Cure Various Skin Conditions [0] Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets [0] Inflamax Research selected by the Immune Tolerance Network and the National Institutes of Health to conduct a landmark clinical study on the underlying mechanisms of allergic inflammation.[0] New Genotyping System Identifies Pathogenic E. coli Outbreak Strains

... SkinHealth Technology introduces a skin animation video depicting the ... Treatment Balm on skin affected with psoriasis. ... Psoriasis treatment The powerful, ... and botanical emollients -- with a proven skin protectant ...

... of Technology have for the first time provided ... growing high-quality layers of epitaxial graphene on silicon ... vapor pressure of gas-phase silicon in the high-temperature ... basic principle for growing thin layers of graphene ...

... 2011 SuperNova Diagnostics®, Inc., a privately-held global diagnostics ... that Neil J. Campbell, president and CEO, will be ... D.C. on September 27, 2011 at 11:00 a.m. in ... in Washington, D.C. The presentation will ...

Cached Biology Technology:Skin Animation Highlights New Dermatological Formula That Targets Psoriasis 2 Controlling silicon evaporation allows scientists to boost graphene quality 2 Controlling silicon evaporation allows scientists to boost graphene quality 3 SuperNova Diagnostics® to Present at AdvaMed 2011: The Medtech Conference in Washington, D.C. 2

Skin Animation Highlights New Dermatological Formula That Targets Psoriasis Controlling silicon evaporation allows scientists to boost graphene quality SuperNova Diagnostics® to Present at AdvaMed 2011: The Medtech Conference in Washington, D.C.

(Date:5/19/2013)... have engineered a strain of electricity-producing bacteria that can ... and carbon dioxide as its sole source of carbon. ... their findings at the 113th General Meeting of the ... result of current production solely on hydrogen," says Amit ... his co-authors are part of the Lovley Lab Group ...

(Date:5/18/2013)... presented today at Digestive Disease Week (DDW) explores new ... impact of coffee on autoimmune disease and palliative care ... has been associated with reduced risk of fibrosis, a ... of java each month also correlate with lower risk ... Mayo Clinic, Rochester, MN, linked coffee consumption with reduced ...

(Date:5/17/2013)... Research Foundation announced a new grant that intends to ... one of today,s most exciting areas of science, and ... Awards Panel selected Andrew T. Chan, MD, MPH and ... School, Boston, as the 2013 AGA-Elsevier Gut Microbiome Pilot ... funding, commencing in July 2013, to test the overarching ...

Breaking Biology News(10 mins):Coffee consumption associated with reduced risk of autoimmune liver disease 2 New gut microbiome research to explore red meat -- colorectal cancer pathway 2

[0] Bacteria use hydrogen, carbon dioxide to produce electricity [0] Coffee consumption associated with reduced risk of autoimmune liver disease [0] New gut microbiome research to explore red meat -- colorectal cancer pathway

... Reportlinker.com announces that a new market research ... Biometrics: Technologies and Global Markets ... report studies the global as well as regional markets ... locating newer markets and expanding the present market position ...

... If you,re unsure about what foods to eat to maintain ... to point people back to basics and reach for ... edition of American Journal of Clinical Nutrition reveals ... to an 18% decreased risk of cardiovascular disease. The ...

... TEMPE, Ariz. Enormous uncertainty. These two words ... in the 21st century. Reservoirs have dipped to their ... forecasts for even warmer summers are predicted. Despite this ... need to be fearful because positive impacts can be ...

Reportlinker Adds Biometrics: Technologies and Global Markets Go ahead, drink your milk A positive step in the face of uncertainty

Anti-MMP-19 (RASI), carboxy terminal region; rabbit host...

Rabbit polyclonal to MAP3K12 ( Abpromise for all tested applications). Antigen: Synthetic peptide conjugated to KLH from the C-terminal region of human MAP3K12 Entrez Gene ID: 7786 Swiss ...

Phosphatidylinositol transfer protein beta isoform (PtdIns transfer protein beta) (PtdInsTP) (PI-TP-beta). [Source:Uniprot/SWISSPROT;Acc:P48739] Antigen: Recombinant Protein Epitope Signature Tag...

Desmosomal Protein Immunogen: Full length, native protein purified from human epidermal keratins. Storage: -20 C, Avoid Freeze/Thaw Cycles...

Biology Products:

Rabbit Anti-Human MMP-19 (RASI), carboxy terminal region, Antibody, Unconjugated from CEDARLANE Laboratories Limited Rabbit Anti-MAP3K12 Polyclonal Antibody, Unconjugated from Abcam Rabbit Anti-Human PITPNB Polyclonal Antibody, Unconjugated from Atlas Antibodies Mouse Anti-Desmosomal Protein Monoclonal Antibody, Unconjugated, Clone ZK-31 from ABR-Affinity BioReagents